Press Release Details

View all news

Quest Diagnostics Appoints Lucia Luce Quinn As Senior Vice President, Advanced Diagnostics

10/16/1

TETERBORO, N.J., Oct. 16 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that Lucia Luce Quinn has been appointed Senior Vice President, Advanced Diagnostics.

In this newly created position, Ms. Quinn will be responsible for leading Quest Diagnostics' efforts in aligning strategy, business development and innovation. She will draw upon her experience in marketing and research and development to accelerate the rate at which Quest Diagnostics brings new products and services to market.

Ms. Quinn joined Quest Diagnostics in April, 2001, as Vice President, Developing Businesses. Previously, she served as Vice President, Corporate Strategic Marketing at Honeywell International. She has over 25 years of experience in general management, marketing, operations, business planning and strategy development with global technology companies, including Allied Signal, Digital Equipment, and Westinghouse.

Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services with $3.4 billion in annual revenues. The company's diagnostic testing yields information that enables health care professionals and consumers to make better decisions to improve health. Quest Diagnostics offers patients and physicians the broadest access to diagnostic testing services through its national network of approximately 30 full-service laboratories, 150 rapid response laboratories and more than 1,300 patient service centers, where specimens are collected. Quest Diagnostics is the leading provider of esoteric testing, including gene-based testing, and is the leader in routine medical testing, drugs of abuse testing, and non-hospital-based anatomic pathology testing. Through partnerships with pharmaceutical, biotechnology and information technology companies, Quest Diagnostics provides support to help speed the development of health care insights and new therapeutics. Additional company information can be found on the Internet at: http://www.questdiagnostics.com.

                    MAKE YOUR OPINION COUNT -  Click Here
               http://tbutton.prnewswire.com/prn/11690X37337740

SOURCE Quest Diagnostics Incorporated

CONTACT: Gary Samuels, Media, +1-201-393-5700, or Cathy Doherty, Investors, +1-201-393-5030, both of Quest Diagnostics Incorporated/

Categories: Press Releases
View all news